ERYTECH Announces Results from TRYbeCA-1 Phase 3 Trial of
ERYTECH Announces Results from TRYbeCA-1 Phase 3 Trial of Eryaspase in Patients with Second-line Advanced Pancreatic Cancer Management to host Conference...
Source: globenewswire.com
Page 23 - Pharma Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pharma Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pharma Bio Today - Breaking & Trending Today
Nicox Provides Third Quarter 2021 Business and Financial Highlights
Press ReleaseNicox Provides Third Quarter 2021 Business and Financial Highlights VYZULTA and ZERVIATE prescriptions in the U.S. increased by 35% and 213% respectively in Q3 2021 compared
Source: finanznachrichten.de
Nicox Provides Third Quarter 2021 Business and Financial
Press ReleaseNicox Provides Third Quarter 2021 Business and Financial Highlights VYZULTA® and ZERVIATE® prescriptions in the U.S. increased by 35% and...
Source: globenewswire.com
United States Market for Laboratory Analytical & Life
Dublin, Oct. 07, 2021 (GLOBE NEWSWIRE) -- The "The US Market for Laboratory Analytical & Life Science Instrumentation 2021" report has been added to...
Source: globenewswire.com
Nicox Provides Second Quarter 2021 Business and Financial Highlights and Strategic Update
Nicox Provides Second Quarter 2021 Business and Financial Highlights and Strategic Update Lead value drivers are 100% ownership of NCX 470 and NCX 4251 in the U.S . 21 C sufficient for the Company to meet its current requirements for the next twelve months July 16, 2021 - release at 7:30 am CET Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, provided business and financial highlights for Q2 2021 for Nicox SA and its subsidiaries (the "Nicox Group") as well as an update on its strategy and key expected value-inflection milestone...
Source: finanznachrichten.de